- Home
- CDNA vs INNV Comparison
CDNA vs INNV Comparison
Compare CDNA & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- INNV
- Stock Information
- Founded
- CDNA 1998
- INNV 2007
- Country
- CDNA United States
- INNV United States
- Employees
- CDNA N/A
- INNV N/A
- Industry
- CDNA Medical Specialities
- INNV Medical/Nursing Services
- Sector
- CDNA Health Care
- INNV Health Care
- Exchange
- CDNA Nasdaq
- INNV Nasdaq
- Market Cap
- CDNA 944.1M
- INNV 817.8M
- IPO Year
- CDNA 2014
- INNV 2021
- Fundamental
- Price
- CDNA $24.48
- INNV $5.97
- Analyst Decision
- CDNA Buy
- INNV Hold
- Analyst Count
- CDNA 8
- INNV 2
- Target Price
- CDNA $28.00
- INNV $6.50
- AVG Volume (30 Days)
- CDNA 984.5K
- INNV 38.4K
- Earning Date
- CDNA 11-04-2024
- INNV 11-05-2024
- Dividend Yield
- CDNA N/A
- INNV N/A
- EPS Growth
- CDNA N/A
- INNV N/A
- EPS
- CDNA N/A
- INNV N/A
- Revenue
- CDNA $297,084,000.00
- INNV $763,855,000.00
- Revenue This Year
- CDNA $18.40
- INNV $15.06
- Revenue Next Year
- CDNA $6.91
- INNV $10.04
- P/E Ratio
- CDNA N/A
- INNV N/A
- Revenue Growth
- CDNA N/A
- INNV 11.01
- 52 Week Low
- CDNA $4.80
- INNV $3.52
- 52 Week High
- CDNA $34.84
- INNV $6.61
- Technical
- Relative Strength Index (RSI)
- CDNA 35.38
- INNV 53.15
- Support Level
- CDNA $24.65
- INNV $5.33
- Resistance Level
- CDNA $31.52
- INNV $6.35
- Average True Range (ATR)
- CDNA 2.32
- INNV 0.31
- MACD
- CDNA -0.73
- INNV 0.06
- Stochastic Oscillator
- CDNA 2.64
- INNV 66.96
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.